Blue gradient background with vertical rounded lines in varying shades of blue scattered across the right side.Blue gradient background with vertical rounded lines in varying shades of blue scattered across the right side.
On-demand education
Filter
FILTER BY TESTS
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Prognostic implications of tumor diameter in association with gene expression profile for uveal melanoma. JAMA Ophthalmol 2016;134(7):734-40.

July 1, 2016
DecisionDx-UM
Authors: Walter SD, Chao DL, Feuer W, et al.
Prognostic
Ophthalmology

Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes. JAMA Ophthalmol 2016;134(7):728-33.

July 1, 2016
DecisionDx-UM
Authors: Decatur CL, Ong, E, Garg, N, et al.
Prognostic
Ophthalmology

Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes. JAMA Ophthalmol 2016;134:728-33.

July 1, 2016
DecisionDx-UM
Authors: Decatur CL, Ong E, Garg N, et al.
Prognostic
Ophthalmology

Clinical performance and management outcomes with the DecisionDx-UM gene expression profile test in a prospective multicenter study. J Oncol 2016; doi:10.1155/2016/5325762.

June 30, 2016
DecisionDx-UM
Authors: Plasseraud KM, Cook RW, Tsai T, et al.
Prognostic
Ophthalmology

A Tissue Systems Pathology Assay for High-Risk Barrett’s Esophagus

May 31, 2016
Exploration of a tissue systems pathology approach to predict progression in patients with non-dysplastic Barrett's esophagus.
TissueCypher
Barrett's Esophagus
Authors: Rebecca J. Critchley-Thorne
Prognostic
Gastroenterology
Publication

Uveal melanomas with SF3B1 Mutations: a distinct subclass associated with late-onset metastases. Ophthalmology 2016;123:1118-28.

May 1, 2016
DecisionDx-UM
Authors: Yavuzyigitoglu S, Koopmans AE, Verdijk RM, et al.
Prognostic
Ophthalmology

Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma. Nat Genet 2016;48:675-80.

April 18, 2016
DecisionDx-UM
Authors: Moore AR, Ceraudo E, Sher JJ, et al.
Prognostic
Ophthalmology

PRAME as an independent biomarker for metastasis in uveal melanoma. Clin Cancer Res 2016;22(5):1234-42.

March 1, 2016
DecisionDx-UM
Authors: Field MG, Decatur CL, Kurtenbach S, et al.
Prognostic
Ophthalmology

Independent prognostic significance of gene expression profile class and largest basal diameter of posterior uveal melanomas. Am J Ophthalmol 2016;162:20-7e1.

February 1, 2016
DecisionDx-UM
Authors: Correa ZM & Augsburger JJ.
Prognostic
Ophthalmology

Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4. Oncotarget 2016;7:4624-31.

December 14, 2015
DecisionDx-UM
Authors: Johansson P, Aoude LG, Wadt K, et al.
Prognostic
Ophthalmology

Clinical characteristics of uveal melanoma in patients with germline BAP1 mutations. JAMA Ophthalmol 2015;133:881-7.

August 1, 2015
DecisionDx-UM
Authors: Gupta MP, Lane AM, DeAngelis MM, et al.
Prognostic
Ophthalmology

Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases. Clin Genet 2016;89:285-94.

June 22, 2015
DecisionDx-UM
Authors: Rai K, Pilarski R, Cebulla CM, et al.
Prognostic
Ophthalmology